Sponsor:
AI-Spectral
Code:
NCT07446582
Conditions
Age-Related (Dry) Macular Degeneration
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Accepted
Interventions
Retina imaging device (MSI-120) and AI (DeepMSI AI)
Brief summary:
Conditions
Age-Related (Dry) Macular Degeneration
Study ID
NCT07446582
Start date
Feb 1, 2026
Status verified date
Mar, 2026
Completion date
Sep 5, 2026
Anticipated
Primary completion date
Sep 5, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Accepted
Enrollment
1000 participants
Anticipated
Arms
AMD eyes
Healthy eyes
Interventions
Retina imaging device (MSI-120) and AI (DeepMSI AI)
Primary outcome measure
Central contacts
Emily Zhang, MD. PhD
EmilyZ@deepmsi.comLocations
Contact Lens & Vision
Recruiting
Woodbridge, New Jersey, United States, 07095
Contacts
Principal Investigator:
Stephen Sinclair, MD.
Sponsor
AI-Spectral
Last update posted
Mar 11, 2026
Last verified
Mar, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-25. This information was provided to ClinicalTrials.gov by AI-Spectral on 2026-03-11. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.